Category: Healthcare M&A Blog

Selling your hospice in 2026 — Vallexa Advisors hospice M&A guide. Stat block shows 447 hospices suspended and $600M Medicare fraud crackdown.

Selling Your Hospice in 2026: What the Crackdown Means for Valuation, Exit & Buyer Demand

Federal regulators just suspended Medicare payments to 447 hospices and 23 home health organizations over $600M+ in alleged fraudulent billing. For clean hospice owners weighing a sale, this is the strongest seller’s market in five years — but only if your books, compliance file, and process are ready. Here’s what your hospice is worth in 2026, how the buyer landscape has shifted, and the 7-step confidential sale process Vallexa Advisors runs for every hospice client.

Read more
The home-based care sector has entirely transitioned away from the undisciplined "growth at all costs" mindset that characterized the post-pandemic boom. In its place has emerged a highly disciplined marketplace focused resolutely on sustainable operating margins, strict clinical compliance, and strategic geographic density.1 As market multiples, capital costs, and valuation frameworks evolve, mastering the 2026 home health care m&a landscape is not merely an advantageous exercise—it is the foundational prerequisite for securing a premium valuation and executing a successful exit.

How to Value and Sell a Home Care Business in 2026

Who this guide is for
Owners thinking, “I want to sell my home care business” or “I want to sell my home care agency”
Franchise owners asking, “How do I sell my home care franchise?”
Operators comparing a home care business appraisal versus a market-based sale strategy
Owners who want to improve value before going to market
Founders who want to sell confidentially and avoid a sloppy public process
Home health owners who need to understand how compliance, quality reporting, and reimbursement complexity affect value

Read more